China United Network Communications Group Co., Ltd. (China Unicom) opened the base station at the top of the Huoshenshan Hospital, a makeshift hospital for COVID-19 treatment in Wuhan, after 36 hours of construction, installation and adjustment.
The nucleic acid test kit for the novel coronavirus developed by Shanghai GeneoDx Biotech Co., LTD of China National Biotec Group Company Limited, a subsidiary of China National Pharmaceutical Group Co., Ltd. (Sinopharm), passed quality assessment of the National Medical Products Administration and was ready for the anti-epidemic fight.